In addition, the retention of the SSTR2 antagonists in the HSC may be shorter, because there is less potential for rebinding of ligands that have dissociated from the surface of the cells, which are important mechanisms for their long retention in the tumor tissue 48, 49. Here, SSTR2 is linked to neoplasm.